258 related articles for article (PubMed ID: 27098676)
1. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
[TBL] [Abstract][Full Text] [Related]
2. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.
Quaife SL; Ruparel M; Dickson JL; Beeken RJ; McEwen A; Baldwin DR; Bhowmik A; Navani N; Sennett K; Duffy SW; Wardle J; Waller J; Janes SM
Am J Respir Crit Care Med; 2020 Apr; 201(8):965-975. PubMed ID: 31825647
[No Abstract] [Full Text] [Related]
3. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract][Full Text] [Related]
4. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
Kummer S; Waller J; Ruparel M; Duffy SW; Janes SM; Quaife SL
Thorax; 2020 Dec; 75(12):1065-1073. PubMed ID: 33087548
[TBL] [Abstract][Full Text] [Related]
5. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
6. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
7. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
[No Abstract] [Full Text] [Related]
9. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
12. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.
Allgood PC; Maroni R; Hudson S; Offman J; Turnbull AE; Peacock L; Steel J; Kirby G; Ingram CE; Somers J; Fuller C; Threlfall AG; Gabe R; Maxwell AJ; Patnick J; Duffy SW
Lancet Oncol; 2017 Jul; 18(7):972-980. PubMed ID: 28522311
[TBL] [Abstract][Full Text] [Related]
13. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
Crosbie PAJ; Gabe R; Simmonds I; Hancock N; Alexandris P; Kennedy M; Rogerson S; Baldwin D; Booton R; Bradley C; Darby M; Eckert C; Franks KN; Lindop J; Janes SM; Møller H; Murray RL; Neal RD; Quaife SL; Upperton S; Shinkins B; Tharmanathan P; Callister MEJ
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35777775
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial testing acceptance of practitioner-referral versus self-referral to stop smoking services within the Lung Screen Uptake Trial.
Kotti T; Katsampouris E; Ruparel M; McEwen A; Dickson JL; Duffy SW; Waller J; Janes SM; Quaife SL
Addiction; 2023 Oct; 118(10):2007-2013. PubMed ID: 37331722
[TBL] [Abstract][Full Text] [Related]
15. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
[TBL] [Abstract][Full Text] [Related]
16. Mapping the spectrum of psychological and behavioural responses to low-dose CT lung cancer screening offered within a Lung Health Check.
Kummer S; Waller J; Ruparel M; Cass J; Janes SM; Quaife SL
Health Expect; 2020 Apr; 23(2):433-441. PubMed ID: 31961060
[TBL] [Abstract][Full Text] [Related]
17. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.
Marteau TM; Mann E; Prevost AT; Vasconcelos JC; Kellar I; Sanderson S; Parker M; Griffin S; Sutton S; Kinmonth AL
BMJ; 2010 May; 340():c2138. PubMed ID: 20466791
[TBL] [Abstract][Full Text] [Related]
18. Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.
Gilbert H; Sutton S; Morris R; Petersen I; Wu Q; Parrott S; Galton S; Kale D; Magee MS; Gardner L; Nazareth I
Health Technol Assess; 2017 Jan; 21(3):1-206. PubMed ID: 28121288
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
20. Invitation methods for Indigenous New Zealand Māori in lung cancer screening: Protocol for a pragmatic cluster randomized controlled trial.
Parker K; Colhoun S; Bartholomew K; Sandiford P; Lewis C; Milne D; McKeage M; McKree Jansen R; Fong KM; Marshall H; Tammemägi M; Rankin NM; Hotu S; Young R; Hopkins R; Walker N; Brown R; Crengle S
PLoS One; 2023; 18(8):e0281420. PubMed ID: 37527237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
